These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8141838)

  • 21. Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels.
    Alaupovic P; Heinonen T; Shurzinske L; Black DM
    Atherosclerosis; 1997 Aug; 133(1):123-33. PubMed ID: 9258416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein and apolipoprotein distribution in Zucker rats following an endurance running program.
    Shepherd RE; Durstine JL; Davis RA
    Atherosclerosis; 1985 Oct; 57(1):107-17. PubMed ID: 3865655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of cholesterol synthesis reduces low-density-lipoprotein apoprotein B production without decreasing very-low-density-lipoprotein apoprotein B synthesis in rabbits.
    La Ville A; Moshy R; Turner PR; Miller NE; Lewis B
    Biochem J; 1984 Apr; 219(1):321-3. PubMed ID: 6562889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men.
    Vega GL; Grundy SM
    Am J Cardiol; 1998 Feb; 81(4A):36B-42B. PubMed ID: 9526812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesterol is required for the secretion of the very-low-density lipoprotein: in vivo studies.
    Khan BV; Fungwe TV; Wilcox HG; Heimberg M
    Biochim Biophys Acta; 1990 Jun; 1044(3):297-304. PubMed ID: 2364096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular processing of apolipoprotein B-containing lipoproteins from young post-infarction patients and healthy controls.
    Tornvall P; Regnström J; Hamsten A
    Eur J Clin Invest; 1995 Sep; 25(9):699-707. PubMed ID: 7498246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects.
    Watts GF; Naoumova RP; Kelly JM; Riches FM; Croft KD; Thompson GR
    Am J Physiol; 1997 Sep; 273(3 Pt 1):E462-70. PubMed ID: 9316434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of hydroxymethylglutaryl coenzyme A reductase activity does not affect the secretion rate of apolipoproteins B and AI by CaCo-2 cells.
    Pau E; He Y; Lougheed M; Steinbrecher UP
    Biochem Cell Biol; 1995; 73(1-2):81-90. PubMed ID: 7662319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
    Forster LF; Stewart G; Bedford D; Stewart JP; Rogers E; Shepherd J; Packard CJ; Caslake MJ
    Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
    Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D
    Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of lovastatin on concentrations and composition of lipoprotein subfractions.
    Nozaki S; Vega GL; Haddox RJ; Dolan ET; Grundy SM
    Atherosclerosis; 1990 Oct; 84(2-3):101-10. PubMed ID: 2282090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysis.
    Wanner C; Hörl WH; Luley CH; Wieland H
    Kidney Int; 1991 Apr; 39(4):754-60. PubMed ID: 2051734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
    Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
    Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
    Chung BH; Segrest JP; Franklin F
    Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Manipulation of cholesterol and cholesteryl ester synthesis has multiple effects on the metabolism of apolipoprotein B and the secretion of very-low-density lipoprotein by primary hepatocyte cultures.
    Brown A; Wiggins D; Gibbons GF
    Biochim Biophys Acta; 1999 Sep; 1440(2-3):253-65. PubMed ID: 10521709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, decreases apolipoprotein B-100 secretion from Hep G2 cells.
    Ooyen C; Zecca A; Bersino AM; Catapano AL
    Atherosclerosis; 1999 Jul; 145(1):87-95. PubMed ID: 10428299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia.
    Schulzeck P; Bojanovski M; Jochim A; Canzler H; Bojanovski D
    Lancet; 1988 Mar; 1(8586):611-3. PubMed ID: 2894548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of obesity on the metabolism of apolipoprotein B in humans.
    Egusa G; Beltz WF; Grundy SM; Howard BV
    J Clin Invest; 1985 Aug; 76(2):596-603. PubMed ID: 4031064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.